Systemic fungal infections are being recognized with increasing frequency in extremely premature neonates. We report two such infants with late-onset mixed infection with Staphylococcal species and unusual fungi. These cases are of interest in view of recent reports on the interaction of Staphylococcal cell wall components and neutrophils, as damaged skin sites could form a nidus and portal of entry for saprophytic fungal pathogens. It is also important to consider fungal infection as a possibility in sick premature infants with necrotic skin lesions even when the systemic signs have an alternative explanation with ongoing bacteremia.
INTRODUCTION
Invasive fungal infections continue to be associated with substantial morbidity and mortality in preterm infants. 1 We report two extremely low-birth-weight (ELBW) infants who had a mixed infection with Staphylococcal species and unusual fungal pathogens.
CASE 1
A 24-week, 737 g female infant was born by vaginal delivery to a 37-year-old third gravida mother after an uneventful antenatal period. Apgar scores were 7 and 8 at 1 and 5 minutes, respectively. Neonatal problems included hyaline membrane disease requiring mechanical ventilation, ductal patency-treated medically with indomethacin on days of life 2 to 3, neonatal hyperbilirubinemia treated with phototherapy, and a grade IV intraventricular hemorrhage detected on day of life 7. Owing to worsening respiratory status with pulmonary interstitial emphysema and evolving chronic lung disease, she was started on intravenous dexamethasone on day of life 14 for a total of 7 days. She had an umbilical arterial and venous catheter for days of life 1 to 3, a radial arterial line placed and removed on day of life 8, and a percutaneous central catheter for days 8 to 28.
A sepsis work-up was done on day of life 26 for new-onset hypotension and higher ventilatory requirements, and she was started presumptively on intravenous vancomycin and cefotaxime. Her CBC was significant for a white cell count of 22,000 with an I/T ratio of 0.27. The blood cultures (peripheral and central) were positive for coagulase-negative staphylococcus and fungus, which was later identified as Trichosporon asahii. The urine and CSF remained sterile. Cefotaxime was discontinued, and Amphotericin B was added to the medication regimen. As repeat blood cultures drawn on days 28, 31, and 34 continued to be positive for Trichosporon spp. despite removal of the central line, 5-flucytosine was added on day 34. To exclude end organ seeding, an indirect ophthalmoscopic examination and a renal sonogram were obtained, which were both unremarkable. Repeat cultures on day of life 36 were negative. Vancomycin was continued for a total of 14 days. A cumulative dose of 20 mg/kg of Amphotericin B and 2 weeks of 5-flucytosine were administered without any evidence of renal, hepatic or hematologic adverse effects. The patient recovered with no further complications related to this infection. On followup, she had normal growth and developmental parameters for corrected age at 9 months.
CASE 2
A 26-week, 675 g, small for gestational age, male infant was born by elective Cesarean section for breech presentation to a 32-year second-gravida mother with a history of systemic lupus erythematosus, renal failure, and severe hypertension. She was on prednisone, minoxidil, labetalol, phenytoin, and aspirin therapy. Apgar scores were 5 and 8 at 1 and 5 minutes, respectively. His clinical course was complicated by hyaline membrane disease needing mechanical ventilation, ductal patency treated initially with indomethacin therapy on days of life 2 to 4 and later, with surgical ligation on day 26, and neonatal hyperbilirubinemia treated with phototherapy. He also had persistent hypotension and hypoglycemia noted from later part of the first day, and was presumptively treated for adrenal insufficiency (secondary to maternal corticosteroid therapy) with hydrocortisone. He was treated with intravenous Ampicillin and Gentamicin for a total of 7 days. He had an umbilical arterial and venous catheter for days of life 1 to 4, and a percutaneous central catheter for days 8 to 26.
On day of life 8, a 3 cm Â 2 cm necrotic lesion with eschar was noted on the left leg over the anteromedial aspect of tibia. On the same day, he also had borderline low blood pressures and hypoglycemia. His CBC and cultures sent on the same day were negative, but a repeat set on day of life 10 grew Staphylococcus aureus within 24 hours, and Curvularia lunata after 4 days. Cultures on urine and cerebrospinal fluid remained sterile. Surface cultures from the leg lesion also grew Curvularia. A skin biopsy done from this site on day of life 12 showed presence of filamentous fungal hyphae on microscopy. He also developed an effusion in the left knee joint on day of life 15, which was aspirated, and also grew Curvularia. The fungal isolate was sensitive to Amphotericin B, but resistant to Itraconazole, Fluconazole, and 5-flucytosine. Local surgical debridement was done on day 20. He was treated with Vancomycin for 14 days, Amphotericin B for a total of 21 days (20 mg/kg), and Rifampin for 9 days. Screening renal sonography was negative, but a detailed eye examination could only be accomplished satisfactorily at 5 weeks of age when the clarity of intraocular media had improved. Repeat cultures remained negative. The patient recovered with no further complications attributable to this infection.
DISCUSSION
Trichosporon and Curvularia are very unusual human pathogens, and reports of neonatal colonization or invasive disease are rare. [2] [3] [4] [5] Both Trichosporon asahii (formerly known as Trichosporon beigelii) and Curvularia lunata are ubiquitous fungi found naturally in soil and in stagnant or fresh water. 6, 7 Trichosporon species usually cause superficial infections involving hair, nails and skin, and invasive infections are seen mostly in the immunocompromised host. 8 Curvularia, similarly, is associated most often with allergic fungal sinusitis, but can cause disseminated infection in immunodeficiency. 7 In premature infants, Curvularia infection has been described as an invasive fungal dermatitis from a primary skin focus, or as a disseminated infection with embolic phenomena. Immaturity of the skin barrier and the effects of local trauma have been postulated as a mechanism for direct invasion. 4, 7 Trichosporonosis has been reported in a spectrum of disease severity ranging from skin/venous catheter colonization, localized urinary tract infection, pneumonia to disseminated infection. Although the pathophysiologic mechanisms have not been clearly defined, the portal of entry of trichosporonosis is believed to be through the skin or tracheal/gastrointestinal mucosa. 9, 10 Both our patients had multiple risk factors for nosocomial infection and fungal disease, including extreme prematurity, central catheters, endotracheal intubation, total parenteral nutrition, ranitidine prophylaxis against stress ulceration, antibiotic therapy, and steroid admninistration. [11] [12] [13] In the second case, early-onset colonization with unusual organisms from the mother, who had been on immunosuppressive therapy, cannot be excluded.
14 Mixed bacterial-fungal infections have been reported previously in patients with indwelling central catheters, but are perceived mainly as a product of mixed colonization and the relationship of Staphylococci and fungal pathogens has not received specific attention. 15 While shared predisposing factors 16 can certainly explain this concurrence, it is also of interest that Staphylococcal cell wall components such as lipoteichoic acid and protein A enhance the interaction between the stratum corneum and neutrophils. 17, 18 At the site of Staphylococcal invasion through damaged skin, infiltrating neutrophils interact with opsonized corneocytes in a form of frustrated phagocytosis, and can thus amplify local tissue damage. 17 As both Curvularia and Trichosporon are opportunistic saprophytic pathogens, it is possible that sites such as these might form an optimal nidus and portal of entry. Further prospective clinical observation is needed, however, to determine if such mixed infections would have a more prolonged or severe course. These cases also reiterate the need to consider cutaneous fungal infections in the differential diagnosis in critically sick neonates with necrotic skin lesions, even when an alternative diagnosis such as bacteremia can explain the systemic signs of illness. As many of these fungal pathogens are fastidious and difficult to culture, a biopsy is often the only reliable diagnostic modality available to the clinician. It is also unclear if neonates with these unusual fungal pathogens need extensive screening for end organ seeding as is recommended for Candidemia. In our first case, we performed these tests when the cultures remained persistently positive. In the second infant, the issue of screening was more difficult as the ophthalmoscopic examination remained limited in hazy intraocular media. A clear negative report was obtained only at 5 weeks of age during routine screening for retinopathy of prematurity.
In systemic fungal infections in neonates, Amphotericin B has been the gold standard of therapy, although use of other agents and combinations including 5-flucytosine and azoles is being explored. 19 Fungal susceptibilities can be difficult to standardize but the sensitivity profile of the Curvularia isolate in our second case is a cause for concern. The presence of primary resistance against azoles and 5-flucytosine in our isolate underscores the need for continued caution in the choice of therapeutic agents in this condition. The availability of newer antifungal agents with broader spectra of activity against these emerging pathogens is encouraging, although their use is currently limited by the lack of experience in neonates and children. 20, 21 Further evaluation of the pathogenesis and treatment strategies of opportunistic fungal infections are needed.
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